Description: BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Home Page: www.bbbiotech.ch/en/bb-biotech/
Seestrasse 16
Küsnacht,
CH-8700
Switzerland
Phone:
41 44 2676700
Officers
| Name | Title |
|---|---|
| Dr. Daniel Koller Ph.D. | Head of Biotech, Portfolio Manager and Member of Executive Board |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 16.4024 |
| Price-to-Book MRQ: | 0.9229 |
| Price-to-Sales TTM: | 15.5752 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 10 |